IDEX Corporation has raised its 2026 organic sales growth forecast to 5-6% from a previous range of 3-4%, citing a stronger order backlog in its Health & Science Technologies segment and improving demand in its industrial operations. In the second quarter of 2026, the HST segment's organic sales rose 12% and organic orders climbed 47%, extending backlog visibility into 2027, while the Fluid & Metering Technologies segment posted a 1% increase in organic sales and an 11% rise in orders on solid municipal water and mining demand. Acquisitions added 1% to consolidated sales growth and 2% to HST sales growth in the quarter, reflecting the July 2025 purchase of Micro-LAM, which expanded IDEX's materials science and optics capabilities across aerospace and defense. The company returned $106.7 million in dividends and $153.4 million in share repurchases in the first six months of 2026, and its board increased the share repurchase authorization to $1 billion in September 2025, leaving $774.7 million available at the end of the second quarter. The Zacks Consensus Estimate for IDEX's 2026 earnings stands at $8.83 per share, up 11.1% year over year, with 2027 earnings projected at $9.64 per share, up 9.2%.
Helios Technologies Inc
RBC Bearings IncorporatedIDEX CorporationIDEX returned $106.7M dividends and $153.4M buybacks in H1 2026 and lifted its repurchase authorization to $1 billion.
China Dvlp Bk Finl Leasing Co
Generac Holdings Inc